Quest Diagnostics
673 hedge funds and large institutions have $12.7B invested in Quest Diagnostics in 2018 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 205 increasing their positions, 246 reducing their positions, and 48 closing their positions.
33% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 48
2% more funds holding
Funds holding: 662 → 673 (+11)
3% less capital invested
Capital invested by funds: $13.1B → $12.7B (-$392M)
1.67% less ownership
Funds ownership: 88.03% → 86.36% (-1.7%)
17% less repeat investments, than reductions
Existing positions increased: 205 | Existing positions reduced: 246
42% less call options, than puts
Call options by funds: $42.3M | Put options by funds: $73.1M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$126M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$85.7M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$63M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$52.4M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$33.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$124M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$94.6M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$81.6M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$65.8M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$62M |
DGX Hedge Fund Activity: Q3 2018 in Review
673 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2018, worth a combined $12.7B — down 3% from $13.1B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new DGX positions and 48 closed out — a net gain of 16 holders — while 205 added to existing stakes and 246 trimmed.
The largest buyer was American Century Companies, adding an estimated $126M. The largest seller was BlackRock, cutting an estimated $124M.
- 673 institutional investors held Quest Diagnostics (DGX) as of Q3 2018, up from 662 in Q2 2018.
- Funds reported $12.7B of Quest Diagnostics stock for Q3 2018, down 3% quarter-over-quarter.
- 64 funds opened new Quest Diagnostics positions in Q3 2018 and 48 closed out, a net change of +16 holders.
- The largest Quest Diagnostics buyer in Q3 2018 was American Century Companies, an estimated $126M added.
- The largest Quest Diagnostics seller in Q3 2018 was BlackRock, an estimated $124M sold.
Based on aggregated 13F filings for Q3 2018.